BioCentury
ARTICLE | Clinical News

Mentax data

May 6, 1996 7:00 AM UTC

DERM reported data from one of its two Phase III studies of Mentax for athlete's foot. In the double-blind, randomized, vehicle-controlled trial, 80 patients with positive cultures received either Men...